--- title: "Dow Climbs 0.72% as ASML Gains, S&P 500 Up 0.22%" canonical_url: https://www.stockexpertai.com/journal/2026-05-30/dow-climbs-072-as-asml-gains-sp-500-up-022-3 last_updated: 2026-05-30T12:18:42.304Z section: "Big Story" author: "Sam Rivera" publisher: Stock Expert AI tickers: ASML, CELU, CRDF, FE content_type: journal-article --- # Dow Climbs 0.72% as ASML Gains, S&P 500 Up 0.22% ## The Take - The Dow's outperformance suggests a rotation towards value stocks, while investors should monitor CELU and CRDF for developments regarding their respective corporate challenges. _Mixed market performance sees the Dow Jones outperform while small caps lag._ The Dow Jones Industrial Average climbed 0.72% to 51,032.46 points, leading major indices higher. The S&P 500 also saw gains, rising 0.22% to 7,580.06 points. However, the Nasdaq 100 only edged up 0.36% to 30,333.18 points, indicating a more muted tech sector performance compared to the broader market. Small caps, as represented by the IWM ETF, declined -0.55% to $290.43. The VIX, a measure of market volatility, decreased by -2.67% to 15.32 points, suggesting a slight easing of investor fear. ASML Holding NV shares rose 0.44%, bringing the current price to $1612.76. The stock is considered overvalued by some valuation metrics, despite a high GF Score of 92 out of 100. FirstEnergy (FE) also saw a modest gain of 0.43%, closing at $46.39. This comes as FirstEnergy recently filed a $3 billion shelf prospectus to offer debt and equity securities, aiming to bolster its capital structure and support future growth initiatives. Conversely, Celularity (CELU) faces challenges after receiving a noncompliance notice from Nasdaq. The notice raises concerns about Celularity's ability to meet listing requirements, which could negatively impact its stock price and investor confidence. CELU shares were up 1.92% to $1.01, but the Nasdaq notice is a significant overhang for investors. Cardiff Oncology (CRDF) is embroiled in a dispute with NMS, which alleges a breach of agreement over Cardiff patents inventorship and failure to use commercially reasonable efforts for Onvansertib. Cardiff Oncology disputes the termination notice, asserting it will continue under the agreement. CRDF shares increased 3.26% to $1.90 amid this uncertainty. Commodities showed mixed performance. Gold rose 1.34% to $4593.00 per ounce, while silver dipped slightly by -0.05% to $75.88 per ounce. Oil (WTI) decreased by -1.73% to $87.36 per barrel, and copper fell by -0.58% to $6.39 per pound. Natural gas saw a slight increase of 0.15% to $3.29 per MMBtu. In the cryptocurrency market, Bitcoin edged up 0.06% to $73447.74, while Ethereum increased 0.32% to $2012.02. The dollar index (DXY) decreased slightly by -0.08% to 98.94 points, indicating a marginal weakening of the U.S. dollar. ## Related Tickers - [ASML](https://www.stockexpertai.com/stock/asml) - [CELU](https://www.stockexpertai.com/stock/celu) - [CRDF](https://www.stockexpertai.com/stock/crdf) - [FE](https://www.stockexpertai.com/stock/fe) ## Frequently Asked Questions ### What factors are driving the Dow Jones higher? The Dow Jones Industrial Average is climbing due to positive performance in certain sectors, including gains in ASML. Broader market sentiment and specific company news, such as FirstEnergy's filing, are also influencing the market's direction. However, the Nasdaq's more modest gains suggest a mixed performance across different sectors. ### What is the impact of the Nasdaq noncompliance notice on Celularity (CELU)? The noncompliance notice from Nasdaq is a significant negative factor for Celularity (CELU). It raises concerns about the company's ability to meet listing requirements, which could negatively impact its stock price and investor confidence. Despite a slight increase in share price today, the notice creates an overhang for investors. --- _AI-generated under human editorial supervision. Educational research, not financial advice._